Global /Canada /Healthcare /Medical Devices /BLO
chevron_leftBack

Cannabix Technologies Inc.

BLO
CSE: BLO Delayed
0.6200CAD 3.3%
0.4477 USD
As of 24 April 2025, Cannabix Technologies Inc. has a market cap of $51.55M USD, ranking #24559 globally and #727 in Canada. It ranks #2488 in the Healthcare sector, and #304 in the Medical Devices industry.
Global Rank
24559
Country Rank
727
Sector Rank
2488
Industry Rank
304
Key Stats
Market Cap
$51.55MUSD
71.39M CAD
Enterprise Value
$49.53MUSD
68.59M CAD
EBITDA (TTM)
-$2.22MUSD
-3.08M CAD
Net Income (TTM)
-$2.4MUSD
-3.32M CAD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Ravinder Mlait open_in_new
Founded
2011
Website
cannabixtechnologies.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.3% -3.2% 5.3% 64% 33% 140%

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
BLO
Cannabix Technologies Inc
ISIN: CA13765L1013
Shares Out.:
115.144M1 Shares Float: 105.547M2
TV:
SA:
YF:
GF:
BA:
BLO
MS:
0.6200 CAD
Cboe Canada
MIC: NEOE
BLO
Cannabix Technologies Inc
ISIN: CA13765L1013
TV:
SA:
YF:
GF:
BA:
BLO
MS:
0.6000 CAD
OTC Markets
MIC: OTCM
BLOZF
Cannabix Technologies Inc
ISIN: CA13765L1013
TV:
SA:
YF:
GF:
BA:
MS:
0.4425 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cannabix Technologies Inc.

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath systems, including cannabix mass spectrum (MS) breath sampler for mass spectrometers, optimized for breath collection and ionization that replaces the chromatography step and offers clinical and toxicology laboratories that analyzes nonvolatile species in breath; and cannabix breath collection unit that collects breath samples from the field onto a novel cartridge, which is taken and analyzed with the MS breath sampler. The company offers Breath Logix (BR-LGX), an industrial series a fully automated breath alcohol screening system for employee, contractor, and visitor access control that is self-administered, non-invasive, and has both non-contact and direct straw modes. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

Similar Companies

Industry: Medical Devices (Canada)
Name
Market Cap diff.
Profound Medical Corp.
PRN
$144.68M
200.37M CAD
181%
Theralase Technologies Inc.
TLT
$35.03M
48.52M CAD
-32%
Perimeter Medical Imaging AI, Inc.
PINK
$27.35M
37.87M CAD
-47%
Ventripoint Diagnostics Ltd.
VPT
$17.66M
24.46M CAD
-66%
Aurora Spine Corp.
ASG
$17.61M
24.39M CAD
-66%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.18B
437K%
Boston Scientific Corp.
BSX
$146.31B
284K%
Stryker Corp.
SYK
$136.3B
264K%
Medtronic plc
MDT
$107.41B
208K%
Siemens Healthineers AG
SHL
$58.0B
50.97B EUR
112K%